Unicycive Therapeutics Inc

Stocks Under $10 Biotech Stocks Healthcare Stocks

$6.69

+0.50 (+8.08%)

As of Feb 8, 2:08 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 13 93%

Hold 1 7%

Sell 0 0%

Price Target

Analyst Price Target -6.3% upside

Low Target $3.63

Average Target $6.27

High Target $7.20

Current Price $6.69

Current
$6.69

Target
$6.27

$3.63 $6.27 avg $7.20

Scenario Analysis

Bear Case

$3.63

-45.7%

Low target

Base Case

$6.27

-6.3%

Avg target

Bull Case

$7.20

+7.6%

High target

Risk/Reward

0.2x

Unfavorable

Price in Context

52-Week High

$5.07

32.0% from high

52-Week Low

$2.63

+154.4% from low

Target vs 52W High

$6.27

+23.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%